诺诚健华（上交所代码：688428；香港联交所代码：09969）是一家商业化 阶段的生物医药高科技公司，专注于恶性肿瘤及自身免疫性疾病领域的一类新药研 制。公司现有多个新药产品处于商业化、临床及临床前研发阶段。公司在北京、南 京、上海、广州、香港以及美国设有分支机构。 

InnoCare (HKEX: 09969; SSE: 688428) is a commercial stage biopharmaceutical  company committed to discovering, developing, and commercializing first-in-class  and/or best-in-class drugs for the treatment of cancer and autoimmune diseases with  unmet medical needs in China and worldwide. InnoCare has branches in Beijing,  Nanjing, Shanghai, Guangzhou, Hong Kong, and United States.

地址：北京市昌平区科技园区生命园路8号院一区8号楼

Building 8, 8 Life Science Park Road, ZGC Life Science

Park, Changping District, Beijing, P.R.China

电话：13810762316